Tjuntu Muhlen‐Schulte

Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey

Henry Badgery, Tjuntu Muhlen‐Schulte, John Zalcberg, Bianka D'souza et autres

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Accurate preoperative assessment using computed tomography (CT) to determine resectability is crucial in ensuring patients are offered the most appropriate therapeutic strategy. Despite the use of classification guidelines, any …

au (code pays fourni par la source)

The SYMPTOM‐upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help‐seeking in Australian upper gastrointestinal cancer patients

Napin Karnchanachari, Shakira Milton, Tjuntu Muhlen‐Schulte, Ri Scarborough et autres

OBJECTIVE: There is limited evidence on the development of pancreatic and oesophagogastric cancer, how patients decide to seek help and the factors impacting help-seeking. Our study, the first in Australia, aimed to explore symptom appraisal and diagnostic pathways in these patients. A …

au, gb, qa (code pays fourni par la source)

The Upper Gastrointestinal Cancer Registry: Biliary Cancer Clinical Quality Registry Pilot Results

Charles Pilgrim, Jennifer Holland, Tjuntu Muhlen‐Schulte, Mary Quinn et autres

au (code pays fourni par la source)